Augmented Reality in the Chemical Industry

|

article image
Chemical Companies Deliver Outstanding Customer Experiences Through Digital Transformation” and the second post “5 Benefits of Digital Transformation in Chemical Manufacturing”.  Next week will be the finale of the series predictive analytics in chemical manufacturing. There’s been a lot of hype around technology buzzwords related to the Industrial Internet of Things (IIoT) and Industrie 4.0. And a lot of them hold a great deal of promise in delivering true digital transformation of traditional industry and business operations.

Spotlight

Depomed, Inc.

Depomed, Inc. is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. Founded in 1995, Depomed has successfully executed on strategy of acquiring, integrating and growing differentiated therapeutic products and building each into a strong market presence. The result is a broad portfolio of pain and neurology specialty pharmaceuticals currently comprised of five FDA-approved products. These include the company’s flagship asset, the NUCYNTA® franchise which includes NUCYNTA® ER for the extended management of pain, including neuropathic pain associated with diabetic peripheral neuropathy.

OTHER ARTICLES

The Benefits of Understanding Safety Data Sheets for the Industrial Hygienist

Article | February 13, 2020

As an industrial hygienist, you spend a lot of your time making data-driven decisions. Have you considered the impact of the traceability of the safety data sheets (SDSs) you use to protect your workers? SDSs contain a wealth of information that needs to be evaluated, but who’s writing and reviewing them? Is it someone who has been recognized as a Safety Data Sheet Registered Professional (SDSRPTM)—an expert in their area of practice? The SDSRP designation may not be widely recognizable yet, but it is a very important and unique program in the world of hazard communication.

Read More
CHEMICAL MANAGEMENT

The supply-chain inflation threat to petrochemicals demand

Article | February 13, 2020

Petrochemicals themselves remain in short supply. This is partly because of reduced feedstock from refineries, a consequence of the pandemic-related collapse in transportation fuels demand.Global petrochemical supply is still edging back to something like normal following the US winter storms in February, during which most US capacity was shut down. A point of discussion is whether containers will become available in the right places at the right prices to relieve tightness in the European polyethylene (PE) market, once US supply has normalised. The container issue is making it difficult to move PE and polypropylene (PP) cargoes from Asia to Europe.Market intelligence from the US-based ICIS CDI team indicates that enough container freight space will be available to resume significant shipments of US PE to Europe, albeit at high prices. It will be several more weeks before domestic pipelines have been refilled, enabling US producers to refocus on exports, added CDI.

Read More
CHEMICAL MANAGEMENT

Southeast polyolefins demand growth could be negative again in 2021

Article | February 13, 2020

BEFORE the pandemic, GDP growth rates in the developing world were always higher than in developed economies.And because developing economies had much lower levels of petrochemicals consumption than their rich counterparts, it meant that the multiples over GDP were higher than in the rich word, where consumption was pretty much saturated. For instance, polyethylene (PE) demand in a developed country such as Germany might have grown at 0.3% times GDP whereas in Indonesia the growth could have been one or more times higher than the rate of growth in GDP.But as The Economist wrote in this 11 July article: “In 2021 the poorest countries, which are desperately short of vaccines, are forecast to grow more slowly than rich countries for only the third time in 25 years.” Might the multiples over GDP growth also be adversely affected in the developing world, trending lower than the historic norms? They will almost certainly remain higher than the rich countries. But here is the thing: as millions more people are pushed back into extreme poverty by the pandemic or are denied the opportunity to achieve middle-income status, I believe that developing-world multiples may well decline.Escaping extreme poverty means being able to, say, afford a whole bottle of shampoo for the first time rather than a single-serve sachet, thereby raising per capita polymers consumption.

Read More

What Are Fine Chemicals?

Article | February 13, 2020

The initial versions of drugs were produced by extracting substances from natural herbs and other plants. As understanding and technology in chemistry continued to grow, scientists figured out to isolate and extract a lot more individual compounds from raw materials. The complicated processes that produce these simple, pure substances form the field of fine chemistry. The chemical industry is separated into branches, with fine chemicals serving as the smallest segment of them. Its companions are commodities and specialty chemicals. Commodity chemicals are those that are mass-produced on a big scale to supply global markets. They include general compounds that are the same from supplier to supplier. Specialty chemicals usually are sold as brand name products and are advertised for their distinct qualities and their abilities to carry out functions that other chemicals cannot. They are composed of one or more fine chemicals.

Read More

Spotlight

Depomed, Inc.

Depomed, Inc. is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. Founded in 1995, Depomed has successfully executed on strategy of acquiring, integrating and growing differentiated therapeutic products and building each into a strong market presence. The result is a broad portfolio of pain and neurology specialty pharmaceuticals currently comprised of five FDA-approved products. These include the company’s flagship asset, the NUCYNTA® franchise which includes NUCYNTA® ER for the extended management of pain, including neuropathic pain associated with diabetic peripheral neuropathy.

Events